Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Oragenics Inc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 14 | 16 | +2 |
| Shares | 186.8K | 130.1K | −56.7K (−30.4%) |
| Value | $269.2K | $135.6K | −$133.6K (−49.6%) |
New holders (5)
Institutions that held Oragenics Inc at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 16,510 | $17.2K | 0.00% |
| Lionsbridge Wealth Management LLC | 10,000 | $10.4K | 0.01% |
| UBS Group AG | 990 | $1.03K | 0.00% |
| Activest Wealth Management | 34 | $35 | 0.00% |
| Morgan Stanley | 1 | $1 | 0.00% |
Sold out (3)
Institutions that held Oragenics Inc at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 10,301 | $14.8K |
| FMR LLC | 86 | $124 |
| Wells Fargo & Company | 25 | $36 |